Over-expression of specific CYPs has been observed in tumours and progressive CYP over-activation is now implicated as a mechanism of resistance to cancer treatments (Michael and Doherty, 2005; Rochat, 2005; van Eijk et al., 2019). Here, PPIG is linked to cancer.